Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 4
Submit an article Journal homepage
486
Views
53
CrossRef citations to date
0
Altmetric
Drug Evaluations

Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders

Jorge Castillo The Miriam Hospital, Division of Hematology and Oncology, 164 Summit Ave, Fain Building, Providence, RI 02906, USA +1 401 793 4645; +1 401 793 7132; [email protected]
, MD,
Cannon Milani The Miriam Hospital, Division of Hematology and Oncology, 164 Summit Ave, Fain Building, Providence, RI 02906, USA +1 401 793 4645; +1 401 793 7132; [email protected]
, MD &
Daniel Mendez-Allwood Boston University School of Medicine, Roger Williams Medical Center, Department of Medicine, Providence, RI, USA
, MD
Pages 491-500 | Published online: 01 Apr 2009

Citations (53)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Xiaolan Lv, Liming Wang, XiaoRong Zou & Shigao Huang. (2021) Umbilical Cord Mesenchymal Stem Cell Therapy for Regenerative Treatment of Rheumatoid Arthritis: Opportunities and Challenges. Drug Design, Development and Therapy 15, pages 3927-3936.
Read now
Komal Rao, Sabahat Aziz, Talat Roome, Anam Razzak, Bushra Sikandar, Khawar Saeed Jamali, Muhammad Imran, Tooba Jabri & Muhammad Raza Shah. (2018) Gum acacia stabilized silver nanoparticles based nano-cargo for enhanced anti-arthritic potentials of hesperidin in adjuvant induced arthritic rats. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 597-607.
Read now
James P Sheridan, Randy R Robinson & John W Rose. (2014) Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis. Expert Review of Clinical Pharmacology 7:1, pages 9-19.
Read now
Sally Hamour, Alan D Salama & Charles D Pusey. (2010) Management of ANCA-associated vasculitis: Current trends and future prospects. Therapeutics and Clinical Risk Management 6, pages 253-264.
Read now
Jorge Castillo & Kimberly Perez. (2010) The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies. Journal of Blood Medicine 1, pages 1-8.
Read now
Paulo Fontoura. (2010) Monoclonal antibody therapy in multiple sclerosis. mAbs 2:6, pages 670-681.
Read now
Mathias Buttmann. (2010) Treating multiple sclerosis with monoclonal antibodies: a 2010 update. Expert Review of Neurotherapeutics 10:5, pages 791-809.
Read now
Deborah A. Thomas, Farhad Ravandi, Michael Keating & Hagop M. Kantarjian. (2009) Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy. Leukemia & Lymphoma 50:sup1, pages 27-31.
Read now

Articles from other publishers (45)

Zeineb Zian, Abubakar Umar Anka, Hamisu Abdullahi, Emna Bouallegui, Shayan Maleknia & Gholamreza Azizi. 2024. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal 273 298 .
Yibo Zhan, Min Zhao, Xiaojun Li, Huiying Ouyang, Chenghao Du, Guixian Chen, Zhenzhen Lou, Haoxuan Chen, Yuanqi Zhao & Haoyou Xu. (2023) A meaningful exploration of ofatumumab in refractory NMOSD: a case report. Frontiers in Immunology 14.
Crossref
Huijie Yuan, Meng Pan, Hongxiang Chen & Xuming Mao. (2022) Immunotherapy for Pemphigus: Present and Future. Frontiers in Medicine 9.
Crossref
John C. Molina & Nirali N. Shah. 2022. Clinical Management of Acute Lymphoblastic Leukemia. Clinical Management of Acute Lymphoblastic Leukemia 295 328 .
Lara Herrera, Silvia Santos, Miguel Angel Vesga, Tomas Carrascosa, Juan Carlos Garcia-Ruiz, Antonio Pérez-Martínez, Manel Juan & Cristina Eguizabal. (2021) The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers. Cancers 13:21, pages 5418.
Crossref
Mona Sadeghalvad & Nima Rezaei. 2021. Monoclonal Antibodies. Monoclonal Antibodies.
Agata Pastorczak, Krzysztof Domka, Klaudyna Fidyt, Martyna Poprzeczko & Malgorzata Firczuk. (2021) Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia. Cancers 13:7, pages 1536.
Crossref
Annika Scheffold & Stephan Stilgenbauer. (2020) Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm. Current Oncology Reports 22:2.
Crossref
Miao Yang, Haijing Wu, Ming Zhao, Christopher Chang & Qianjin Lu. (2019) The pathogenesis of bullous skin diseases. Journal of Translational Autoimmunity 2, pages 100014.
Crossref
Kentaro Izumi, Katja Bieber & Ralf J. Ludwig. (2019) Current Clinical Trials in Pemphigus and Pemphigoid. Frontiers in Immunology 10.
Crossref
Talat Roome, Sabahat Aziz, Anam Razzak, Zara Aslam, Lubna, Khawar Saeed Jamali, Bushra Sikandar, Tehseen Fatima, Lubna Abidi, Muhammad Imran, Shaheen Faizi & Muhammad Raza Shah. (2019) Opuntioside, opuntiol and its metallic nanoparticles attenuate adjuvant-induced arthritis: Novel suppressors of Toll-like receptors -2 and -4. Biomedicine & Pharmacotherapy 112, pages 108624.
Crossref
Zahra Payandeh, Armina Alagheband Bahrami, Reyhaneh Hoseinpoor, Yousef Mortazavi, Masoumeh Rajabibazl, Azam Rahimpour, Amir Hossein Taromchi & Saeed Khalil. (2019) The applications of anti-CD20 antibodies to treat various B cells disorders. Biomedicine & Pharmacotherapy 109, pages 2415-2426.
Crossref
Kathleen W. Phelan & Anjali S. Advani. (2018) Novel Therapies in Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports 13:4, pages 289-299.
Crossref
Elaine Vickers. 2018. A Beginner's Guide to Targeted Cancer Treatments. A Beginner's Guide to Targeted Cancer Treatments 259 312 .
Barbara Kiesewetter, Ortrun Neuper, Marius E. Mayerhoefer, Werner Dolak, Julius Lukas, Ingrid Simonitsch-Klupp & Markus Raderer. (2018) A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma. Hematological Oncology 36:1, pages 49-55.
Crossref
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref
Jon A. Kenniston, Brandy M. Taylor, Gregory P. Conley, Janja Cosic, Kris J. Kopacz, Allison P. Lindberg, Stephen R. Comeau, Kateri Atkins, Jameson Bullen, Christopher TenHoor, Burt A. Adelman, Daniel J. Sexton, Thomas E. Edwards & Andrew E. Nixon. (2017) Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody. Journal of Biological Chemistry 292:42, pages 17449-17460.
Crossref
Sander W. Tas & Dominique L. P. Baeten. 2016. Suppression and Regulation of Immune Responses. Suppression and Regulation of Immune Responses 143 155 .
Irit Avivi & Andre Goy. (2015) Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice. Clinical Cancer Research 21:17, pages 3853-3861.
Crossref
Kahkashan Perveen, Farina Hanif, Huma Jawed, Siddiqua Jamall & Shabana Usman Simjee. (2014) N-(2-hydroxy phenyl) acetamide: a novel suppressor of Toll-like receptors (TLR-2 and TLR-4) in adjuvant-induced arthritic rats. Molecular and Cellular Biochemistry 394:1-2, pages 67-75.
Crossref
Arumugam Palanichamy, Sarah Jahn, Dorothee Nickles, Mia Derstine, Aya Abounasr, Stephen L. Hauser, Sergio E. Baranzini, David Leppert & H.-Christian von Büdingen. (2014) Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients. The Journal of Immunology 193:2, pages 580-586.
Crossref
Mark D. Pescovitz, Carla J. Greenbaum, Brian Bundy, Dorothy J. Becker, Stephen E. Gitelman, Robin Goland, Peter A. Gottlieb, Jennifer B. Marks, Antoinette Moran, Philip Raskin, Henry Rodriguez, Desmond A. Schatz, Diane K. Wherrett, Darrell M. Wilson, Jeffrey P. Krischer & Jay S. Skyler. (2014) B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results. Diabetes Care 37:2, pages 453-459.
Crossref
Bharath Wootla, Aleksandar Denic & Moses Rodriguez. 2014. Human Monoclonal Antibodies. Human Monoclonal Antibodies 79 110 .
Stephan Blüml, Kathleen McKeever, Rachel Ettinger, Josef Smolen & Ronald Herbst. (2013) B-cell targeted therapeutics in clinical development. Arthritis Research & Therapy 15:S1.
Crossref
Kathrin Bauer, Michaela Rancea, Verena Roloff, Thomas Elter, Michael Hallek, Andreas Engert & Nicole Skoetz. (2012) Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia. Cochrane Database of Systematic Reviews.
Crossref
Michael R. Pranzatelli, Elizabeth D. Tate, Shalini Shenoy & Anna L. Travelstead. (2012) Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus. Pediatric Blood & Cancer 58:6, pages 988-991.
Crossref
Xiaowen Ge, Lin Wu, Weiguo Hu, Stacey Fernandes, Chun Wang, Xu Li, Jennifer R. Brown & Xuebin Qin. (2011) rILYd4, a Human CD59 Inhibitor, Enhances Complement-Dependent Cytotoxicity of Ofatumumab against Rituximab-Resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia. Clinical Cancer Research 17:21, pages 6702-6711.
Crossref
Britt Nakken, Ludvig A. Munthe, Yrjö T. Konttinen, Anna Klokk Sandberg, Zoltan Szekanecz, Philip Alex & Peter Szodoray. (2011) B-cells and their targeting in rheumatoid arthritis — Current concepts and future perspectives. Autoimmunity Reviews 11:1, pages 28-34.
Crossref
Oscar Fernández. (2011) Nuevos fármacos para el tratamiento de la esclerosis múltiple. FMC - Formación Médica Continuada en Atención Primaria 18:9, pages 582-588.
Crossref
Christian Ehrnthaller, Anita Ignatius, Florian Gebhard & Markus Huber-Lang. (2010) New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System. Molecular Medicine 17:3-4, pages 317-329.
Crossref
Tao You, Weiguo Hu, Xiaowen Ge, Jingnan Shen & Xuebin Qin. (2011) Application of a novel inhibitor of human CD59 for the enhancement of complement-dependent cytolysis on cancer cells. Cellular & Molecular Immunology 8:2, pages 157-163.
Crossref
Daan Dierickx, André Delannoy, Khalid Saja, Gregor Verhoef & Drew Provan. (2011) Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders. American Journal of Hematology 86:3, pages 278-291.
Crossref
Robert O. Dillman. (2011) Cancer Immunotherapy. Cancer Biotherapy and Radiopharmaceuticals 26:1, pages 1-64.
Crossref
Christoph Rader. 2011. Experimental and Applied Immunotherapy. Experimental and Applied Immunotherapy 59 83 .
David Spaner & Angela Bahlo. 2011. Experimental and Applied Immunotherapy. Experimental and Applied Immunotherapy 37 57 .
Evangelia Yannaki, Anastasia Papadopoulou, Evangelia Athanasiou, Panayotis Kaloyannidis, Argyro Paraskeva, Dimitris Bougiouklis, Panayotis Palladas, Minas Yiangou & Achilles Anagnostopoulos. (2010) The proteasome inhibitor bortezomib drastically affects inflammation and bone disease in adjuvant-induced arthritis in rats. Arthritis & Rheumatism 62:11, pages 3277-3288.
Crossref
Holly M. Horton, Matthew J. Bernett, Matthias Peipp, Erik Pong, Sher Karki, Seung Y. Chu, John O. Richards, Hsing Chen, Roland Repp, John R. Desjarlais & Eugene A. Zhukovsky. (2010) Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies. Blood 116:16, pages 3004-3012.
Crossref
Deborah A. ThomasSusan O'BrienStefan FaderlGuillermo Garcia-ManeroAlessandra FerrajoliWilliam WierdaFarhad RavandiSrdan VerstovsekJeffrey L. JorgensenCarlos Bueso-RamosMichael AndreeffSherry PierceRebecca GarrisMichael J. KeatingJorge CortesHagop M. Kantarjian. (2010) Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 28:24, pages 3880-3889.
Crossref
Riad Abès, Emmanuelle Gélizé, Wolf Herman Fridman & Jean-Luc Teillaud. (2010) Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response. Blood 116:6, pages 926-934.
Crossref
Susan Lee & Mark Ballow. (2010) Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases. Journal of Allergy and Clinical Immunology 125:4, pages 814-820.
Crossref
Orhan Aktas, Bernd Kieseier & Hans-Peter Hartung. (2010) Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Trends in Neurosciences 33:3, pages 140-152.
Crossref
Shridhar Hegde & Michelle Schmidt. 2010. 466 537 .
Vladimir Beljanski. 2010. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference 1 4 .
Tadeusz Robak, Krzysztof Jamroziak & Pawel Robak. (2009) Current and Emerging Treatments for Chronic Lymphocytic Leukaemia. Drugs 69:17, pages 2415-2449.
Crossref
Deborah A. Thomas, Susan O'Brien & Hagop M. Kantarjian. (2009) Monoclonal Antibody Therapy with Rituximab for Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America 23:5, pages 949-971.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.